Israel Englander’s NEPHROGENEX INC COM NRX Stock Holding History

Israel Englander’s Portfolio NRX Stock Details NRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-75,000	Closed	-$498K	–	3963
2015 Q2	$498K	Buy	+75,000	New	+$570K	﹤0.01%	2638

Other funds holding NRX

RCP

Rho Capital Partners New York $20.4M AUM

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

VIA

Vantage Investment Advisors State College, Pennsylvania $477M AUM 17.38% 1-Year Est. Return

Israel Englander's NRX Position: Q3 2015 in Review

Israel Englander sold out of NEPHROGENEX INC COM (NRX) in Q3 2015, closing a stake of 75,000 shares — an estimated $498K sold.

Israel Englander first reported a position in NRX in Q2 2015 and held it in 1 quarter. The position peaked at $498K in Q2 2015. 13 funds tracked by Wall St. Rank hold NRX as of Q3 2015.

Israel Englander reported no remaining NEPHROGENEX INC COM position as of Q3 2015 after selling out during the quarter.
Israel Englander sold 75,000 NEPHROGENEX INC COM shares in Q3 2015, an estimated $498K.
Israel Englander first reported a position in NEPHROGENEX INC COM in Q2 2015 and held it in 1 quarter.
Israel Englander's NEPHROGENEX INC COM position peaked at $498K in Q2 2015.
13 funds tracked by Wall St. Rank held NEPHROGENEX INC COM as of Q3 2015.

Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.